Seres Therapeutics, Inc. (MCRB)
5.28
-0.28
(-5.04%)
USD |
NASDAQ |
Sep 09, 16:00
5.28
0.00 (0.00%)
After-Hours: 17:10
Seres Therapeutics Debt to Equity Ratio : 1.640 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.640 |
| March 31, 2026 | 3.038 |
| December 31, 2025 | 1.876 |
| September 30, 2025 | 1.951 |
| June 30, 2025 | 2.654 |
| March 31, 2025 | 1.774 |
| December 31, 2024 | 6.648 |
| September 30, 2024 | 3.914 |
| June 30, 2024 | -2.442 |
| March 31, 2024 | -3.585 |
| December 31, 2023 | -4.432 |
| September 30, 2023 | -14.04 |
| June 30, 2023 | 9.415 |
| March 31, 2023 | -3.399 |
| December 31, 2022 | 15.08 |
| September 30, 2022 | 1.125 |
| June 30, 2022 | 3.348 |
| March 31, 2022 | 0.9589 |
| December 31, 2021 | 0.3742 |
| September 30, 2021 | 0.2492 |
| June 30, 2021 | 0.4436 |
| March 31, 2021 | 0.2759 |
| December 31, 2020 | 0.2333 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.2224 |
| June 30, 2020 | -0.6532 |
| March 31, 2020 | -0.7108 |
| December 31, 2019 | -0.9267 |
| September 30, 2019 | -0.6573 |
| June 30, 2019 | -1.248 |
| March 31, 2019 | -0.3361 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.0203 |
| March 31, 2015 | 0.0349 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 101.59M |
| Total Liabilities (Quarterly) | 67.05M |
| Shareholders Equity (Quarterly) | 34.53M |
| Current Ratio | 2.114 |
| Net Debt Paydown Yield | 8.49% |